Mapinastine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62LN840SFZ. European Medicines Agency schedules Mapinastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08646MIG. Mapinastine generally arises in the molecular formula C23H34N6O. The term MAPINASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) MAPINASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mapinastine under HS 29335995 and SITC 51576. As of Q4 2014, MAPINASTINE remains the US FDA Preferred Term for this commodity. Mapinastine bears US NLM identifiers UMLS ID C1881605 and NCI Concept Code C66055. SMILES: O(CCN1C(NC2C1CCCC2)CN1CCN(CC1)CCCCN1NCCC1)CC.